NEW YORK--(BUSINESS WIRE)--Critical Diagnostics today announced publication of a key opinion article describing the utility of the cardiac biomarker ST2 for assessing cardiac risk in the emergency department. The article, published in the College of American Pathologists journal CAP Today is titled “ST2 in the ED: Will it nail cardiac risk.” The article summarizes the opinion and experience of an international group of key thought leaders in the utilization of biomarkers in the application of emergency medicine and cardiology. The consensus is that, although still at an early stage of development, the ST2 assay shows great promise as a valuable tool in treating patients who are diagnosed with cardiovascular disease or who present with symptoms of cardiovascular disease.
